RNA

EnPlusOne Biosciences Launches Enzymatic RNA Synthesis Platform with $12 Million in Seed Financing
BioSpace
Sun, 10/2/22 - 07:42 pm
EnPlusOne Biosciences
enzymatic RNA synthesis
funding
RNA
Carver Bio Plants Seed to Treat Viral Threats with CRISPR Cas13
BioSpace
Thu, 09/15/22 - 11:20 pm
Carver Bio
CRISPR
funding
infectious diseases
RNA
gene therapy
Drugging RNA with pills: small molecules for a big frontier
BioPharma Dive
Mon, 09/12/22 - 10:37 am
RNA
drug development
Beam-linked startup launches with an eye on the next generation of RNA drugs
BioPharma Dive
Wed, 09/7/22 - 10:24 am
Orbital Therapeutics
Beam Therapeutics
RNA
R&D
Merck Makes Another Big R&D Investment with $3.5B Orna Deal
BioSpace
Tue, 08/16/22 - 12:10 pm
Merck
RNA
Orna Therapeutics
oncology
infectious disease
Biotech startup Eclipse Bio emerges to shed light on RNA drug research
MedCity News
Wed, 03/16/22 - 10:05 am
Eclipse Bio
funding
RNA
R&D
RNA biotech Nutcracker Therapeutics unshells $167M for drugs built on biochips
MedCity News
Tue, 03/15/22 - 10:20 am
Nutcracker Therapeutics
funding
RNA
biochips
A new biotech out of Dana-Farber wants to join the long non-coding RNA party, with help from Bob Langer
Endpoints
Tue, 03/1/22 - 10:27 am
RNA
biotech
NextRNA Therapeutics
funding
IncRNAs
Remix Therapeutics signs Janssen licensing deal that could top $1B
Fierce Biotech
Thu, 02/17/22 - 10:53 am
Remix Therapeutics
RNA
Janssen
JNJ
small molecule drugs
Oncotelic Hopes to Leverage Intranasal Apomorphine to Treat Parkinson’s Disease
BioSpace
Mon, 10/4/21 - 10:57 pm
Oncotelic
immuno-oncology
RNA
small molecule drugs
Parkinson's Disease
erectile dysfunction
AstraZeneca makes RNA play, teaming up with startup to advance twist on red-hot modality
Fierce Biotech
Thu, 09/23/21 - 11:06 am
AstraZeneca
RNA
vaccines
VaxEquity
After selling to Genentech, the old Jecure team is back at an RNA-focused startup — and more enthusiastic than ever
Endpoints
Tue, 09/21/21 - 10:47 am
Genentech
Jecure Therapeutics
NASH
RNA
858 Therapeutics
Eli Lilly Pursues RNA Editing in New Partnership with ProQR
Xtalks
Mon, 09/13/21 - 10:43 am
Eli Lilly
RNA
gene editing
ProQR Therapeutics
Ionis collaborator Flamingo is ready to take flight with 3 antisense drugs in the clinic and mysterious RNA in its sights
Endpoints
Thu, 09/9/21 - 11:01 am
Ionis Pharmaceuticals
antisense
Flamingo Therapeutics
RNA
Eli Lilly follows up MiNA pact with a 2nd $1B-plus RNA collab, this time with ProQR
Fierce Biotech
Wed, 09/8/21 - 11:28 pm
Eli Lilly
RNA
gene silencing
ProQR Therapeutics
Venture capital pours more money into RNA medicines with the launch of Replicate
BioPharma Dive
Wed, 09/8/21 - 11:10 am
RNA
venture capital
Replicate Biosciences
Apple Tree Partners
Moderna Bolsters mRNA Oncology Business with Autolus' Proprietary Binders
BioSpace
Tue, 08/3/21 - 10:54 am
Autolus Therapeutics
Moderna Therapeutics
RNA
cancer
Deep Genomics, now flush with cash, plans to take dozens of RNA therapies to the clinic
Endpoints
Wed, 07/28/21 - 10:07 am
Deep Genomics
RNA
funding
artificial intelligence
As Arrowhead falters, lungs remain a tough target for RNA drugs
BioPharma Dive
Wed, 07/7/21 - 11:00 am
RNA
Arrowhead
ARO-ENaC
cystic fibrosis
A new RNA startup looks to reimagine heart treatments, with eyes set on Entresto
Endpoints
Thu, 05/20/21 - 11:04 pm
RNA
Haya Therapeutics

Pages